Skip to main content
Article
Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia
British Journal of Haematology (2011)
  • Pamela S. Becker, University of Washington
  • Hagop M. Kantarjian, University of Texas MD Anderson Cancer Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Stephen H. Petersdorf, Fred Hutchinson Cancer Research Center
  • Barry Storer, Fred Hutchinson Cancer Research Center
  • Sherry Pierce, University of Texas MD Anderson Cancer Center
  • Jianqin Shan, University of Texas MD Anderson Cancer Center
  • Paul C. Hendrie, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Andrei R. Shustov, Fred Hutchinson Cancer Research Center
  • Derek L. Stirewalt, Fred Hutchinson Cancer Research Center
  • Stephan Faderl, University of Texas MD Anderson Cancer Center
  • Elizabeth Harrington, Fred Hutchinson Cancer Research Center
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
Publication Date
January 10, 2011
DOI
10.1111/j.1365-2141.2011.08831.x
Citation Information
Pamela S. Becker, Hagop M. Kantarjian, Frederick R. Appelbaum, Stephen H. Petersdorf, et al.. "Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia" British Journal of Haematology Vol. 155 Iss. 2 (2011) p. 182 - 189
Available at: http://works.bepress.com/john-pagel/178/